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Introduction
Several histopathologic variants are defined besides 
the conventional type of papillary thyroid carcinoma 
(PTC) [1]. Reports state that different histopathologic 
carcinomas manifest distinctive biologic behavior and 
various clinical/prognostic features. For example, the tall 
cell, columnar cell and hobnail variants are widely con-
sidered associated with poor outcomes [2]. On the con-
trary, Warthin-like variant PTC (WVPTC) is classified 
into a subgroup with a favorable prognosis. 
Proposed by Apel et al [3] in 1995, WVPTC got the 
name for the close histologic resemblance to Warthin’s 
tumors, which were often encountered in the salivary 
gland. It is characterized by typical papillary foldings 
lined by tumor cells with oncocytic cytoplasm and nucle-
ar features of PTC, accompanied by prominent lympho-
cytic infiltration in the papillary stalks [4]. Prevalence of 
WVPTC is still unclear, ranging about 0.2~1.9% [4,5] of 
the PTC. Most of the publications are case reports. 
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Aim: To summarize the clinical, ultrasonographic (US) and pathological characteristics of Warthin-like variant papil-
lary thyroid carcinomas (WVPTC). Material and methods: Medical records and US images of 32 cases of WVPTCs diag-
nosed between December, 2006 and September, 2018 were reviewed. Clinical, pathological and US characteristics of these 
cases were collected and summarized. ACR TI-RADS was followed during the analysis of the US features of the lesions. 
Results: Totally, 32 patients with 33 WVPTC nodules were reviewed. WVPTC was more often seen in female patients 
(27/32,84.4%) with a relatively high age (mean age, 51.0±10.8 years old). Hyperthyroidism was observed in 14 patients; 
2 patients were diagnosed as subclinical hyperthyroidism and 1 patient as subclinical hypothyroidism. Abnormal thyroglobulin 
antibody was detected in 22 patients. Mean size of the nodule was 1.2±0.5 cm (range, 0.5~2.99 cm) on US. Pathologically, tu-
mor margin of 63.6% carcinomas were infiltrative but most (72.9%) of the enrolled carcinomas were intra-thyroidal. Lympho-
cytic thyroiditis was detected in 87.5% (28/32) patients. On US, most WVPTCs were solid or almost complete solid (32/33, 
97.0%) and very hypoechoic (26/33, 78.8%). Taller-than-wide shape (6/33, 18.2%) and punctate echogenic foci (9/33, 27.3%) 
were not popular. All the nodules were scored higher than 5 points according to the ACR TI-RADS, including 9 nodules that 
were classified into TR4 and 24 nodules as TR5. Follow-up information was available in 31 patients and no recurrence or 
distal metastasis was detected. Conclusions: WVPTC is a rare variant of PTCs with favorable outcomes. Very hypoechoic 
echogenicity, solid or almost complete solid composition are the vital indicators for biopsy, even though the nodule may be 
wider-than-tall and have a lack of punctuate echoic foci. 
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High-resolution ultrasound (US) examination is the 
first-line preoperative modality in evaluating thyroid le-
sions [2,6]. Taller-than-wide shape, irregular/spicular 
margin, microcalcifications, extremely hypoechoic and 
solid composition are universally considered as the ma-
lignant indicators of thyroid cancers. The largest study 
about the US features of WVPTC was conducted by Kim 
et al in 2016 [7]. They concluded that WVPTCs did not 
sufficiently meet the typical suspicious findings men-
tioned above. However, only 9 patients were enrolled 
in the study. Here, we summarized the clinical, US and 
pathological characteristics of WVPTCs detected during 
11 years in our hospital. We believe this is the largest 
study about the sonographic features of WVPTC along 
with the follow-up information up to now.
Material and methods
This is a retrospective study. The protocol was ap-
proved by the Institutional Review Board of the Sever-
ance Hospital of Yonsei University. Informed consents 
were waived because of the retrospective designation.
Patients and clinical data
Two radiologists were invited to search the database 
of surgical pathology and to retrieve all the records of 
WVPTCs. Criteria for diagnosing WVPTC were as fol-
lows [8]: 1) papillary growth pattern, 2) oncocytic cy-
toplasm, 3) nuclear feature of PTC and 4) heavy lym-
phoplasmacytic infiltration. Between 2006 December 
and 2018 September, 35 records were hit among 25659 
surgeries for papillary carcinomas, representing 0.14%. 
Preoperative US images were not available in three 
cases, so we included 32 patients in this study. Clinical 
information, including the age, sex and complaints of 
the patients together with the date and methods of the 
surgery were collected when reviewing the medical re-
cords. Results of thyroid function tests were also collect-
ed, including total T3, free T4, TSH and thyroglobulin 
antibody. Normal range of the thyroid function indexes 
were 0.61~1.16 ng/ml for total T3, 0.80~1.23 ng/dl for 
free T4, 0.41~4.30 uIU/ml for TSH and 0~130.6 IU/ml 
for thyroglobulin antibody. Mean age of the enrolled 
32 patients (5 male and 27 female) was 51.0±10.8 years 
old (range, 30~74 years old). Among these, 12 patients 
were younger than 45 years old when surgeries were con-
ducted. 
US data 
US examinations were performed by one of 16 radiol-
ogists (with 1~34 years’ experiences in thyroid US scan-
ning) according to the working shift. Two high-resolution 
US equipment, IU22 (Philips Medical Systems, USA) 
and E9 (GE Medical Systems, Milwaukee, WI, USA), 
were used during the examinations. Clear ultrasonic im-
ages, including both longitudinal and transversal views 
of the thyroid gland and the nodules, were stored in a pic-
ture archiving and communication system (PACS). Color 
Doppler parameters were adjusted to optimal to illustrate 
the blood signals in the nodule. 
Image analysis
Two radiologists (with 9 and 29 years’ of experience 
in thyroid US examinations, respectively) were invited 
to review the stored images according to the white pa-
per of ACR thyroid imaging, reporting and data system 
(TI-RADS) [6]. All the US features, including compo-
sition, echogenicity, shape, margin and echogenic foci 
were described and scored following the instruction of 
TI-RADS. The final level was determined according to 
the sum of the scores, ranging from TR1 (benign) to TR5 
(high suspicion of malignancy). Besides, location, size, 
vascularity of the nodule (none/minimal/abundant) and 
parenchyma of the surrounding thyroid tissue (homoge-
neous/heterogeneous) were also recorded. 
Pathological data
All the surgeries were performed by one of the two 
groups of surgeons after a careful evaluation of the pa-
tients’ status. All pathological data were extracted di-
rectly by a radiologist from the pathological records. The 
records were made by one group of experienced patholo-
gists according to the criteria of the World Health Or-
ganization International Classification of Thyroid tumors 
[9]. An experienced pathologist was invited to re-review 
the pathology slides and verify the records if necessary. 
Collected data were list as follows: the location (left 
lobe/right lobe/isthmus), margin (infiltrative/expand-
ing/partially infiltrative), involvement (intra-thyroidal/
involve the capsule of the gland/extra-thyroidal soft tis-
sue involved), psammomatous calcifications of the lesion 
(absent/present), associated benign lesions (adenomatous 
hyperplasia/lymphocytic thyroiditis) and affected lymph 
nodes (yes/no).
Statistical analysis
Measurement data were recorded with the decimal 
kept to one place. Count variables were described in ratio.
Results
Clinical and surgical results
Clinical and surgical results of the enrolled patients 
were listed in Table I. Only three patients visited a hos-
pital seeking medical advice because of a palpable mass 
in the neck. Other patients, with no specific complaints, 
were diagnosed during a routine check-up. Most patients 
(31/32, 96.9%) had unifocal WVPTC except one, who 
had two focal of WVPTCs (size, 1.1 cm and 0.5 cm) lo-
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cating in the isthmus and the lower pole of the left lobe, 
respectively. So, the total number of enrolled nodules was 
33. Five patients were found having two PTCs, which are 
one nodule of WVPTC and another nodule of different 
subtype of PTC (including four cases of classic PTCs 
and one case of follicular PTC). Moreover, one patient 
was found to have multifocal PTCs, including two clas-
sic type PTCs, one WVPTC and one follicular type PTC. 
Information about the TNM stage was also listed in ta-
ble I. Pathologically, about 87.5% (28/32) patients were 
diagnosed as lymphocytic thyroiditis. Results of thyroid 
function test were available in 30 patients.
According to the pathological results (listed in table 
II), 63.6% of the WVPTCs have infiltrative margins, 
expanding margin was observed only in 7 (21.2 %) pa-
tients. However, most of (72.7%) the lesions were still 
intrathyroidal. Lymphatic metastasis was detected in 8 
patients (including 6 cases in the central part and 2 cases 
in both central and lateral parts). Among the six patients 
with other subtype of PTCs, only one patient, who had a 
nodule of WVPTC and another nodule of conventional 
PTC, had a lymphatic metastasis in level VI. However, 
it is difficult to decide the origin of the metastasis. About 
half (16/33, 48.5%) of the WVPTCs had psammomatous 
calcifications. Prognoses of the cases were evaluated 
by follow-up. Only one patient was missed during the 
follow-up. The mean period of follow-up was 67.4±25.2 
months (range, 4-138 months). No recurrence or distal 
metastasis was found. 
US findings
Among the 32 patients, 30 patients accepted ultra-
sound guided FNA before the operation. One patient 
underwent ultrasound guided core biopsy examination 
and the other accepted surgery directly. All the patients 
who underwent biopsy were preoperatively diagnosed as 
“papillary carcinoma” (9/31, 29.0%) or “suspicious for 
papillary carcinoma” (22/31, 71.0%). US findings of the 
enrolled cases were summarized in Table III. The mean 
diameter of the nodules was 1.2±0.5 cm (range, 0.5~2.99 
cm). All the cases were scored higher than 5 points ac-
cording to the ACR TI-RADS, including 7 cases were 
classified into TR4 and 26 cases were graded as TR5. 
Most of the lesions were solid or almost complete solid 
(32/33, 97.0%), very hypoechoic (26/33, 78.8%) and 
wider-than-tall shape (27/33, 81.8%) (fig 1 and 2). Only 
Table I. Clinical results of the WVPTC patients
Characteristics Number (%)
Age 32
   <45 12 (37.5%)
   ≥45 20 (62.5%)
   Mean and range 51.0±10.8 (30~74)
Sex 32
   Female 27 (84.4%)
   Male 5 (15.6%)
Location 33
   Left lobe 13 (39.4%)
   Right lobe 16 (48.5%)
   Isthmus 4 (12.1%)
Thyroid Function 30
   Normal 13 (43.3%)
   Hyperthyroidism 14 (46.7%)
   Subclinical hyperthyroidism 2 (15.4%)
   Subclinical hypothyroidism 1 (3.3%)
Abnormal thyroid antibody 22 (73.3%)
TNM staging 32
   T1aN0M0 7 (21.9%)
   T1aN1M0 4 (12.5%)
   T1bN0M0 16 (50.0%)
   T1bN1M0 3 (9.4%)
   T2N0M0 1 (3.1%)
   T2N1M0 1 (3.1%)
Surgery 32
Total thyroidectomy with central  
compartment dissection
20 (62.5%)
Total thyroidectomy with modified 
lymph dissection
2 (6.3%)
Subtotal thyroidectomy with central 
compartment dissection
3 (9.4%)
Hemithyroidectomy with central  
compartment dissection
4 (12.5%)
Hemithyroidectomy without central 
compartment dissection
3 (9.4%)
Table II. Pathological characteristics of the WVPTC patients
Characteristics Number (%)
Tumor margin
   Infiltrative 21 (63.6%)
   Expanding 7 (21.2%)
   Partially infiltrative 2 (6.1%)
   Not mention 3 (9.1%)
Tumor involvement
   Intra-thyroidal 24 (72.7%)
   Extra-thyroidal soft tissue involved 9 (27.3%)
Lymphatic metastasis
   Yes 8 (25.0%)
      Only central LN involved 6 (75.0%)
      Central and lateral LN involved 2 (25.0%)
   No 24 (75.0%)
Psammomatous calcification
   Absent 16 (48.5%)
   Present 14 (42.4%)
   Not mention 3 (9.1%)
Lymphocytic thyroiditis
   Yes 28 (87.5%)
   No 4 (12.0%)
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one case was mixed cystic and solid.  Regarding the mar-
gin, 11 cases were considered to be smooth/ill-defined, 
18 cases were classified into lobulated or irregular, and 
4 cases were suspicious for extra-thyroidal extension. 
Echogenic foci were detected in 11 cases, including 2 
cases with macrocalcifications and 9 cases with punctate 
echogenic foci. Color Doppler images were available 
in 26 cases, most (18/26, 69.2%) cases were classified 
into none blood flow signal group. Among the 28 cases 
with lymphocytic thyroiditis confirmed by pathological 
results, parenchyma of the thyroid gland was described 
as “heterogeneous” in 22 cases and “homogeneous” in 
10 cases. 
Discussions
Thyroid cancer is one of the most commonly seen dis-
eases in clinical practice. Rates for new thyroid cancers 
have been rising on average 3.1% each year over the last 
10 years [10]. A similar tendency is found both in China 
and Korea [11,12]. Several studies reported that, prog-
nosis of patients with PTCs may be associated with both 
clinical features and pathological variants [13-15]. How-
ever, US characters of various PTC subgroups are still 
insufficient [15,16], even though the method was widely 
used as the primary  method in evaluating thyroid lesions.
WVPTC is a rare subgroup of oncocytic variant [1] 
PTC, with about 162 cases reported in the English lit-
erature up to now [4,5,7,8]. Similar to previous reports, 
we found that WVPTC were more often seen in female 
patients (27/32，84.4%) with a relative high age (mean 
age, 51.0±10.8 years old). Thyroid function test showed 
that, though plenty of patients had lymphatic thyroiditis 
and WVPTC simultaneously, incidence of hypothyroid-
ism was not as high as expected; only one patient was 
detected as subclinical hypothyroidism. 
After a thorough literature searching, we found that 
most of the articles published were about the pathologi-
cal characteristics of WVPTCs [8,17-19]. It is widely ac-
cepted that WVPTC is morphologically characterized by 
a papillary architecture with an oncocytic epithelial lin-
ing and lymphoplasmacytic core infiltrate. In this study, 
Fig 1. Transverse (a) and longitudinal (b) views of a 30-year-
old woman with a solid thyroid nodule in the left lobe. The 
nodule was very hypoechoic with ill-defined margins. Three 
punctate echoic foci were noticed on the edge of the nodule. 
It was confirmed as WVPTC.
Fig 2. Transverse(a) and longitudinal (b) sonographic images 
of a WVPTC in a 41-year old woman. The nodule was solid, 
hypoechoic and wider-than-tall shape. Surrounding thyroid pa-
renchyma was heterogeneous, indicating the underling diffuse 
thyroiditis; c) the pathological image of the nodule (×200). Tu-
mor cells showed oncocytic epithelium and dense lymphocytic 
infiltration in the stroma.
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we summarized some pathological information regard-
ing WVPTC, including tumor margin, involvement and 
lymph metastasis. Results showed that the tumor margin 
was infiltrative in 63.6% nodules and partially infiltra-
tive in 2 nodules.  Regarding the involvement, 71.8% 
carcinomas were intra-thyroidal. During the follow-up, 
neither local recurrence nor distal metastasis was de-
tected. Thus, we agree with the statement that WVPTCs 
is a kind of variant with a favorable prognosis [5,18,20] 
though there was one fatal case reported [21]. It is also 
widely accepted that Hashimoto’s thyroiditis usually pre-
sents in the nonneoplastic thyroid tissue in patients with 
WVPTC [20,22]. In our case series, 87.5% patients were 
diagnosed as lymphatic thyroiditis simultaneously. Pre-
operative abnormal thyroglobulin antibody was detected 
in 22 patients. So, it is important to differentiate WVPTC 
with other thyroid diseases with lymphocytic infiltration, 
such as Hashimoto thyroiditis, malignant lymphoma, 
the tall cell variant of PTC, etc. Fortunately, previous 
studies reported that PTCs with Hashimoto’s thyroiditis 
(HT)/ chronic lymphocytic thyroiditis (CLT) are less ag-
gressive than those without HT/CLT [19,23,24]. How-
ever, we are not sure about the relationship between the 
prognosis of WVPTC and HT due to the limited sample 
size. 
We analyzed the WVPTCs enrolled in this study ac-
cording to the ACR TI-RADS system. All the cases were 
scored higher than 5 points. Though 78.8% cases were 
categorized as highly suspicious (TR5), further analysis 
showed that 11 cases scored 7 and only 6 cases manifest-
ing typical US malignant characteristics (such as solid, 
very hypoechoic echogenicity, taller-than-wide shape 
with punctate echoic foci) scored 10~13. So, we believe 
that US appearance of WVPTC is quite non-specific and 
the final diagnosis relies on pathologic examinations. 
FNA was a recommendable way for the preoperative di-
agnosis. According to the ACR TI-RADS, FNA should 
be suggest to 20 patients including 3 cases in TR4 with 
a nodule larger than 1.5 cm and 17 cases in TR5 with a 
nodule larger than 1.0 cm, and follow-up should be sug-
gested to the other 12 patients. In our series, 11 more pa-
tients underwent FNA because they were worried about 
adverse consequences during the follow-up. Though all 
the biopsies resulted as “papillary carcinoma” (9/31, 
29.0%) or “suspicious for papillary carcinoma” (22/31, 
71.0%), none of them were diagnosed as WVPTC direct-
ly. We assume the reason was that the nuclear feature of 
classical PTC was easily detected in cytological samples 
as well as the lymphatic infiltration. However, the pap-
illary growth pattern and the dense lymphoplasmacytic 
infiltration in the cores of the papillae were more obvious 
in surgical specimen. Similar results were also reported 
previously by Chong et al and Vallonthaiel et al [17,25].
Similar with conventional variant PTCs, most of 
WVPTCs enrolled in our study were solid or almost 
complete solid and very hypoechoic. This feature was the 
main suspicious indicator for FNA. In accordance with 
Kim et al findings [7], we found that taller-than-wide 
shape in our case series was not popular (18.2%). Be-
sides, punctate echoic foci were detected in 9 cases only. 
So, we assumed that wider-than-tall shape and lack of 
punctate echoic foci were the most important confusing 
factors during the detection of WVPTCs. 
As far as we know, this is the largest study concen-
trated on the sonographic characteristics of WVPTC un-
til now. However, there are still four limitations in our 
study. Firstly, this is a retrospective study performed in a 
single tertiary hospital. Further studies with a larger sam-
ple from multi medical centers are expected to confirm 
our conclusion. Secondly, cases enrolled in our study 
were all surgically removed, though the pathological re-
Table III. Ultrasonographic findings of the enrolled WVPTCs
Composition
   Cystic/almost complete cystic 0
   Spongiform 0
   Mixed cystic and solid 1 (3.0%)
   Solid or almost complete solid 32 (97.0%)
Echogenicity
   Anechoic 0
   Hyperechoic or isoechoic 1 (3.0%)
   Hypoechoic 6 (18.2%)
   Very hypoechoic 26 (78.8%)
Shape
   Wider-than-tall 27 (81.8%)
   Taller-than-wide 6 (18.2%)
Margin
   Smooth/ill-defined 11 (33.3%)
   Lobulated or irregular 18 (54.5%)
   Extra-thyroidal extension 4 (12.1%)
Echogenic foci
   None or large comet-tail artifacts 22 (66.7%)
   Macrocalcifications 2 (6.1%)
   Peripheral calcifications 0
   Punctate echogenic foci 9 (27.3%)
Color Doppler
   None 18 (69.2%)
   Minimal 8 (30.8%)
TI-RADS level
   TR1-3 0
   TR4 7 (21.2%)
   TR5 26 (78.8%)
Parenchyma of the thyroid gland
   Homogeneous 10 (31.2%)
   Heterogeneous 22 (68.8%)
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sults were explicit, selective bias was inevitable. Thirdly, 
only nodules of WVPTC were included in this study; 
no control group or differential diagnosis was designed. 
Fourth, the detection of BRAFV600E  was not a routine test 
in our hospital. Among the enrolled cases, only one pa-
tient accepted the detection test of BRAFV600E and the 
result was positive. So we did not include the result in 
the manuscript. 
In conclusion, WVPTC is a rare variant of PTCs 
with favorable outcomes. Sonographic appearance of 
WVPTC is quite non-specific and the final diagnosis 
relies on pathologic examinations. However, very hy-
poechoic echogenicity, solid or almost complete solid 
composition still are the vital indicators for FNA, even 
though the nodule may be wider-than-tall and without 
punctuate echoic foci.
Conflict of interest: none
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